LEYDEN LABS ASIA PTE. LTD.
Last Updated: 13 Apr 2026
PatSnap's Synapse is a cutting-edge platform that enables life sciences professionals to streamline their research and decision-making processes by providing seamless access to vast amounts of curated, real-time data from various sources. Our AI-powered platform automates ETL in real-time, leveraging natural language processing, machine learning, and other advanced technologies to create a comprehensive big data system. With over 16 million patents, 61 million literature, 69,000 new drugs, 44,000 targets, 13,000 indications, 340,000 pharmaceutical institutions, 850,000 clinical trials, and 100,000 pharmaceutical information, Synapse offers unparalleled insights and opportunities for informed decision-making across the entire innovation cycle.
Country of registration | Singapore |
Registration number | 202201430H |
Local SIC | |
Incorporation date | 12 Jan 2022 |
Company age | 4 years 4 months |
Official entity type | Private Limited Company |
No. of officers | 13 |
Contact
Address:
79 SCIENCE PARK DRIVE, #04-05, CINTECH IV, Singapore 118264
Access Key Decision Makers
This is the legal entity page of LEYDEN LABS ASIA PTE. LTD.. To access company info, company size, news , key makers’ emails, visit the profile pages above.
Associated business (1)
- PATSNAP LIFE SCIENCEView MoreSingaporePatSnap's Synapse is a cutting-edge platform that enables life sciences professionals to streamline their research and decision-making processes by providing seamless access to vast amounts of curated, real-time data from various sources. Our AI-powered platform automates ETL in real-time, leveraging natural language processing, machine learning, and other advanced technologies to create a comprehensive big data system. With over 16 million patents, 61 million literature, 69,000 new drugs, 44,000 targets, 13,000 indications, 340,000 pharmaceutical institutions, 850,000 clinical trials, and 100,000 pharmaceutical information, Synapse offers unparalleled insights and opportunities for informed decision-making across the entire innovation cycle.
This is the legal entity page of LEYDEN LABS ASIA PTE. LTD.. To access company info, company size, news, key maker's emails, visit the profile pages above.
Financials
Auditor | BAKER TILLY TFW LLP |
Revenue | < 1m |
Share Capital - Preference shares | USD 10,000,000 |
Share Capital - Ordinary shares | USD 2,000,000 |
Last updated: 13 Apr 2026
* This information is provided to the best of our research ability and we make no warranties for any inaccuracies or omissions.
Discover More Companies
Lookalike companies
* This profile contains information from ACRA Information on Corporate Entities from Accounting and Corporate Regulatory Authority which is made available under the terms of the Singapore Open Data Licence version 1.0. Information and datasets on our website are provided on an “as is” and “as available” basis. This website makes no representations or warranties concerning the datasets, including but not limited to any representation or warranty as to the accuracy, completeness, reliability, continued availability, timeliness, non-infringement, title, quality, or fitness for any particular purpose of the datasets to the fullest extent permitted by the law.
Frequently Asked Questions (FAQ)
- What is the address of LEYDEN LABS ASIA PTE. LTD.?
- Where is LEYDEN LABS ASIA PTE. LTD.'s headquarter?
- What is LEYDEN LABS ASIA PTE. LTD.'s contact number?
- What LEYDEN LABS ASIA PTE. LTD.'s spending power?
- Does LEYDEN LABS ASIA PTE. LTD. have a presence in the domain it operates in?